Creagen Inc.
Woburn, MA
- UEI
- TR7EMJYU1KL9
- CAGE
- 4TEG8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) Primary
- 325180 Other Basic Inorganic Chemical Manufacturing
- 325199 All Other Basic Organic Chemical Manufacturing
- 325412 Pharmaceutical Preparation Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 334516 Analytical Laboratory Instrument Manufacturing
- 541380 Testing Laboratories and Services
Show all
- 541690 Other Scientific and Technical Consulting Services
- 541713 Research and Development in Nanotechnology
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 561110 Office Administrative Services
- 561320 Temporary Help Services
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- 299 Washington St, Woburn, MA 01801, USA
- Website
- creagenbio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The national institute of diabetes and digestive and kidney diseases conducts and supports biomedical research to… | Office of Logisitics and Acquisition Operations | $56,000 | |
| Niddk supplies: chemical compound synthesis -severable | National Institute of Child Health and Human Development | $94,400 | |
| Custom antibody-conjugated drugs (ADC) services | National Institute on Drug Abuse | $66,000 | |
| Niddk - acquisition of services related to library of bioactive molecules | National Institute of Child Health and Human Development | $80,000 | |
| Small molecule synthesis task order 02 for usamriid | Defense Health Agency | $68,218 |
About Creagen Inc.
Creagen Inc. is a small, minority-owned corporate entity located in Woburn, Massachusetts, specializing in chemistry-based drug discovery and scientific research services. Registered in SAM.gov since 2007, the company is an SBA Certified 8(a) Program Participant and a self-certified small disadvantaged business with expertise in providing specialized scientific services to federal health and medical research agencies. The company offers a range of sophisticated services including custom antibody-conjugated drug development, small molecule synthesis, preclinical research support, and quality assurance/quality control planning for various federal agencies.
Creagen Inc. has been awarded multiple federal contracts across several agencies, primarily focusing on chemical compound synthesis and research support. The contracts have been received from agencies such as the National Institutes of Health (NIH), including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Aging, National Institute of Allergy and Infectious Diseases (NIAID), National Center for Advancing Translational Sciences, and the Defense Health Agency. The company's contract awards have ranged from $8,746 to $80,000, with tasks including developing libraries of bioactive molecules, synthesizing chemical compounds, providing custom antibody-conjugated drug services, and supporting infectious disease research programs. Most contracts have been set aside for small businesses, leveraging Creagen's minority-owned and small business status.
Creagen Inc. holds a significant Indefinite Delivery Contract (IDC) with the Defense Health Agency valued at $1,204,980, awarded in September 2022 and valid through September 2027. This single-award IDC is specifically designed to support the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) infectious disease research program, allowing for the synthesis of 350-450 novel small molecule inhibitor analogs over a five-year period. Under this contract, Creagen has already received two delivery orders totaling approximately $105,427 for small molecule synthesis tasks. The IDC demonstrates the company's capability to provide long-term, specialized scientific research services to federal agencies, particularly in the domain of infectious disease countermeasure research.
Contract vehicles
SBA capabilities narrative
CreaGen Inc. provides contract research services in organic synthesis, medicinal chemistry, lead optimization, small molecules, chemical library synthesis, conjugation chemistry, and antibody drug conjugation chemistry, analytical and bio-analytical chemistry.
We have more than 100 years of combined experience in working with over 48 biotech and pharmaceutical companies and federal institutes.
Our 22,000 sq ft facility has a full suite of infrastructure for synthesis, purification and characterization combined with a highly qualified team of chemists putting us in a strong position to deliver unparalleled drug discovery services to biotech, pharmaceutical companies and Federal research laboratories.
Quick answers
What is Creagen Inc.'s UEI?
Creagen Inc.'s Unique Entity ID (UEI) in SAM.gov is TR7EMJYU1KL9.
What is Creagen Inc.'s CAGE code?
Creagen Inc.'s CAGE code is 4TEG8.
What is Creagen Inc.'s primary NAICS code?
Creagen Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Creagen Inc. located?
Creagen Inc.'s physical address in SAM.gov is 299 Washington St, Woburn, MA 01801, USA.
Is Creagen Inc. registered in SAM.gov?
Yes. Creagen Inc.'s SAM.gov registration is active through November 13, 2026.
Which contract vehicles does Creagen Inc. hold?
Creagen Inc. holds a place on 1 federal contract vehicle: Preclinical Services for HIV Therapeutics.
What is Creagen Inc.'s most recent federal award?
Creagen Inc.'s most recent federal contract award is The national institute of diabetes and digestive and kidney diseases conducts and supports biomedical research to… (75N98026P01258), from Office of Logisitics and Acquisition Operations, on August 10, 2026.
On GovTribe
See Creagen Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors